Sentence examples for evaluating lead from inspiring English sources

Navas-Acien et al. (2007) review the epidemiologic evidence evaluating lead exposure and cardiovascular outcomes.

Health-based values or standards developed specifically for evaluating lead in synthetic turf have not been established.

The review by Shih et al. (2007) is a discussion of the epidemiologic evidence evaluating lead exposure and cognitive outcomes.

Similarly, evaluating lead effects using a single blood lead measure may result in measurement error with substantial underestimation of the magnitude of the association.

These results show the importance of copper and iron nutriture and metabolism as factors which reduce lead toxicity, and emphasize the necessity of considering nutritional status in evaluating lead toxicity.

It may also involve developing accurate methods for evaluating lead in labile compartments of the circulation, such as plasma, as a potentially useful and responsive measure of bone lead release, of the partitioning of circulatory lead, and of the toxicological significance of lead released from bone to other target organs.

Based on this literature, and our collective experience in evaluating lead-exposed adults, we recommend that individuals be removed from occupational lead exposure if a single blood lead concentration exceeds 30 μg/dL or if two successive blood lead concentrations measured over a 4-week interval are ≥ 20 μg/dL.

All swale alternatives significantly removed total suspended solids and all metals evaluated: lead, copper, zinc, and cadmium.

She directs the team of equity investment, mergers and acquisitions (M&A) and strategic business development professionals who identify, evaluate, lead and negotiate strategic transactions in businesses focused on the Internet of Things (IoT) and autonomous driving segments.

To our knowledge, ours is one of only a handful of studies in the peer-reviewed literature to evaluate lead leaching into coffee or tea from lead-containing ceramics.

We evaluated lead compound 1 from a novel series of antifolates, 2-amino-4-oxo-5-substituted pyrrolo[2,3-d]pyrimidines as an inhibitor of Cryptosporidium hominis thymidylate synthase with selectivity over the human enzyme.